Evidence map›Paper›PMID 36545094›Full record

ArticleRSC advances2022

SERS combined with PCR as a potent tool for detecting mutations: a case study of tomato plants.

Samyabrata Sen, Divya Chalapathi, Jayaprakash Targolli, Chandrabhas Narayana

Abstract read
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Samyabrata SenChemistry and Physics of Materials Unit, Jawaharlal Nehru Centre for Advanced Scientific Research Bengaluru India cbhas@rgcb.res.in.ORCID https://orcid.org/0000-0002-2756-3431
Divya ChalapathiChemistry and Physics of Materials Unit, Jawaharlal Nehru Centre for Advanced Scientific Research Bengaluru India cbhas@rgcb.res.in.ORCID https://orcid.org/0000-0002-9391-6207
Jayaprakash TargolliBiodecipher Bengaluru India.
Chandrabhas NarayanaChemistry and Physics of Materials Unit, Jawaharlal Nehru Centre for Advanced Scientific Research Bengaluru India cbhas@rgcb.res.in.ORCID https://orcid.org/0000-0001-6256-8994

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conventional methods of detecting economically essential mutations have several disadvantages. Even though fluorescence-based methods are still the best option, Surface-Enhanced Raman Spectroscopy (SERS) may soon emerge as an alternative to the current techniques for detecting these mutations, because of its ability to detect molecular vibrational signatures. We were able to identify and develop a PCR-based SERS assay that can relentlessly differentiate between different types of indels, and SNPs as demonstrated in the case of tomato genome related to tomato yellow leaf curl virus and root-knot nematodes, diseases that are economically significant to the global agriculture industry and where the selection of resistant crops is the best solution. This tri-primer assay utilizes mutation-specific forward primers and SERS probes tagged with FAM and Cy3 dyes, specific for each allele of a particular gene (Ty-3 and Mi-1). The unique Raman spectral features of these dyes enabled to perform of multiplexing, which made it possible to detect not only the indel type but also the zygosity in a single experiment. Moreover, this technique successfully differentiated between two different SNP-based alleles. Therefore, due to its efficient multiplexing capability and lack of the need for quenchers, it has the potential to become a powerful onsite and offsite screening tool in the not-too-distant future.

Identifiers

PMID36545094
PMCPMC9752429

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.